142 related articles for article (PubMed ID: 22954205)
1. Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours.
Olsson H; Hultman P; Rosell J; Jahnson S
Scand J Urol; 2013 Jun; 47(3):188-95. PubMed ID: 22954205
[TBL] [Abstract][Full Text] [Related]
2. HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladder.
Olsson H; Fyhr IM; Hultman P; Jahnson S
Scand J Urol Nephrol; 2012 Apr; 46(2):102-7. PubMed ID: 22150625
[TBL] [Abstract][Full Text] [Related]
3. Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series.
Bertz S; Denzinger S; Otto W; Wieland WF; Stoehr R; Hofstaedter F; Hartmann A
Histopathology; 2011 Oct; 59(4):722-32. PubMed ID: 22014053
[TBL] [Abstract][Full Text] [Related]
4. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
6. Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder.
Turan T; Efiloğlu Ö; Günaydin B; Özkanli Ş; Nikerel E; Atiş G; Çaşkurlu T; Yildirim A
Int Braz J Urol; 2018; 44(2):267-272. PubMed ID: 29219283
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.
van Rhijn BW; Liu L; Vis AN; Bostrom PJ; Zuiverloon TC; Fleshner NE; van der Aa MN; Alkhateeb SS; Bangma CH; Jewett MA; Zwarthoff EC; Bapat B; van der Kwast TH; Zlotta AR
BJU Int; 2012 Oct; 110(8):1169-76. PubMed ID: 22448597
[TBL] [Abstract][Full Text] [Related]
8. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
[TBL] [Abstract][Full Text] [Related]
9. Use of bacillus Calmette-Guérin in stage T1 bladder cancer: Long-term observation of a population-based cohort.
Patschan O; Holmäng S; Hosseini A; Liedberg F; Ljungberg B; Malmström PU; Rosell J; Jahnson S
Scand J Urol; 2015 Apr; 49(2):127-32. PubMed ID: 25331368
[TBL] [Abstract][Full Text] [Related]
10. Outcome of very large superficial bladder tumours: a 10-year experience.
Gupta SK; Parr NJ
Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
[TBL] [Abstract][Full Text] [Related]
11. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder.
May M; Bastian PJ; Brookman-May S; Burger M; Bolenz C; Trojan L; Michel MS; Herrmann E; Wülfing C; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Gilfrich C; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Gunia S; Fritsche HM
Scand J Urol Nephrol; 2011 Sep; 45(4):251-7. PubMed ID: 21388337
[TBL] [Abstract][Full Text] [Related]
12. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
[TBL] [Abstract][Full Text] [Related]
13. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
Green DA; Rink M; Hansen J; Cha EK; Robinson B; Tian Z; Chun FK; Tagawa S; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF
BJU Int; 2013 Mar; 111(3):404-11. PubMed ID: 22805163
[TBL] [Abstract][Full Text] [Related]
14. [Surveillance and prognosis of "T1" superficial tumors of the bladder. Homogeneous series of 88 cases followed for 1 to 22 years].
Lachand AT; Texier J; Texier P
Prog Urol; 2001 Jun; 11(3):472-7. PubMed ID: 11512460
[TBL] [Abstract][Full Text] [Related]
15. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma.
Kondylis FI; Demirci S; Ladaga L; Kolm P; Schellhammer PF
J Urol; 2000 Apr; 163(4):1120-3. PubMed ID: 10737479
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
18. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic factors in T1 superficial bladder carcinoma. Our experience].
Moyano Calvo JL; Romero Díaz A; Ortíz Gamiz A; Sánchez Sánchez E; Blanco Palenciano E; Arribas Rodríguez JM; Castiñeiras Fernández J
Arch Esp Urol; 1999 Jun; 52(5):465-70. PubMed ID: 10427884
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the lymphovascular invasion in high-grade stage pT1 bladder cancer.
Branchereau J; Larue S; Vayleux B; Karam G; Bouchot O; Rigaud J
Clin Genitourin Cancer; 2013 Jun; 11(2):182-8. PubMed ID: 23276589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
